330 related articles for article (PubMed ID: 32863964)
1. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis.
Tang H; Li C; Zhang Y; Zheng H; Cheng Y; Zhu J; Chen X; Zhu Z; Piao JG; Li F
Theranostics; 2020; 10(21):9865-9887. PubMed ID: 32863964
[No Abstract] [Full Text] [Related]
2. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells.
Tang H; Chen D; Li C; Zheng C; Wu X; Zhang Y; Song Q; Fei W
Int J Pharm; 2019 Dec; 572():118782. PubMed ID: 31678528
[TBL] [Abstract][Full Text] [Related]
3. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
[TBL] [Abstract][Full Text] [Related]
4. Targeted GSH-exhausting and hydroxyl radical self-producing manganese-silica nanomissiles for MRI guided ferroptotic cancer therapy.
Fei W; Chen D; Tang H; Li C; Zheng W; Chen F; Song Q; Zhao Y; Zou Y; Zheng C
Nanoscale; 2020 Aug; 12(32):16738-16754. PubMed ID: 32578659
[TBL] [Abstract][Full Text] [Related]
5. Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma.
Gan H; Chen L; Sui X; Wu B; Zou S; Li A; Zhang Y; Liu X; Wang D; Cai S; Liu X; Liang Y; Tang X
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():395-403. PubMed ID: 30033270
[TBL] [Abstract][Full Text] [Related]
6. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic Cancer-Targeting Nanoplatform Boosting AIEgens-Based Photodynamic Therapy and Ferroptosis by Disrupting Redox-Homeostasis.
Wan Y; Cao Y; Hu D; Lai Q; Liu Y; Chen Y; Wu M; Feng S
ACS Biomater Sci Eng; 2024 Jun; 10(6):3813-3824. PubMed ID: 38779799
[TBL] [Abstract][Full Text] [Related]
8. Cystine supplementation rebalances the redox homeostasis of microenvironment in non-small cell lung cancer cells and reverses their resistance to docetaxel.
Li SJ; Cao B; Lu ZY; Sun RB; Guo SH; Xie Y; Aa JY; Wang GJ
Acta Pharmacol Sin; 2021 Dec; 42(12):2132-2143. PubMed ID: 33658706
[TBL] [Abstract][Full Text] [Related]
9. Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.
Tang X; Chen L; Li A; Cai S; Zhang Y; Liu X; Jiang Z; Liu X; Liang Y; Ma D
Drug Deliv; 2018 Nov; 25(1):1484-1494. PubMed ID: 29916268
[TBL] [Abstract][Full Text] [Related]
10. Manganese-Based Redox Homeostasis Disruptor for Inducing Intense Ferroptosis/Apoptosis Through xCT Inhibition And Oxidative Stress Injury.
Dong Q; Wang J; Liu J; Zhang L; Xu Z; Kang Y; Xue P
Adv Healthc Mater; 2023 Nov; 12(28):e2301453. PubMed ID: 37531240
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
Ren J; Zhou J; Liu H; Jiao X; Cao Y; Xu Z; Kang Y; Xue P
Theranostics; 2021; 11(19):9470-9491. PubMed ID: 34646381
[No Abstract] [Full Text] [Related]
12. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of siNRF2 and Sorafenib by a "Click" Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma.
Tong R; Feng X; Sun J; Ling Z; Wang J; Li S; Yang B; Deng J; He G; Wu J
Small; 2024 May; 20(21):e2307273. PubMed ID: 38102096
[TBL] [Abstract][Full Text] [Related]
14. Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics.
Wang S; Li F; Qiao R; Hu X; Liao H; Chen L; Wu J; Wu H; Zhao M; Liu J; Chen R; Ma X; Kim D; Sun J; Davis TP; Chen C; Tian J; Hyeon T; Ling D
ACS Nano; 2018 Dec; 12(12):12380-12392. PubMed ID: 30495919
[TBL] [Abstract][Full Text] [Related]
15. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
16. Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.
Liu J; Zhao X; Nie W; Yang Y; Wu C; Liu W; Zhang K; Zhang Z; Shi J
Theranostics; 2021; 11(1):379-396. PubMed ID: 33391481
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy.
Liu Y; Wang X; Feng H; Li X; Yang R; Zhang M; Du Y; Liu R; Luo M; Li Z; Liu B; Wang J; Wang W; An F; Niu F; He P
J Nanobiotechnology; 2024 May; 22(1):299. PubMed ID: 38812031
[TBL] [Abstract][Full Text] [Related]
18. A glucose-depleting silica nanosystem for increasing reactive oxygen species and scavenging glutathione in cancer therapy.
Ong WK; Jana D; Zhao Y
Chem Commun (Camb); 2019 Nov; 55(89):13374-13377. PubMed ID: 31633705
[TBL] [Abstract][Full Text] [Related]
19. Synergism through combination of chemotherapy and oxidative stress-induced autophagy in A549 lung cancer cells using redox-responsive nanohybrids: a new strategy for cancer therapy.
Lu HY; Chang YJ; Fan NC; Wang LS; Lai NC; Yang CM; Wu LC; Ho JA
Biomaterials; 2015 Feb; 42():30-41. PubMed ID: 25542791
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
